Skip to content
Unrated Drug recall · FDA · Published April 10, 2019

Lupin Somerset Morphine Sulfate Tablets Recall: Impurities Risk

Lupin Somerset recalls 60mg Morphine Sulfate Extended-Release Tablets due to failed impurities and degradation specifications. Rx-only bottles with specific NDC and lot numbers affected.

🇺🇸 FDA recall #D-1245-2019DrugLupin Somerset ›
Take action

Contact the company

Recalling firmLUPIN SOMERSET400 Campus Dr · Somerset, NJ 08873-1145
✎ GovInfoNow plain-language explainer

Lupin Somerset is recalling 60 mg Morphine Sulfate Extended-Release Tablets (100-count bottles) because they failed impurities and degradation tests. This could pose a risk to patients using these medications. Read more at govinfonow.com/recall/38939-lupin-somerset-morphine-sulfate-tablets-recall-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38939-lupin-somerset-morphine-sulfate-tablets-recall-impurities-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1245-2019

Cite this page

“Lupin Somerset Morphine Sulfate Tablets Recall: Impurities Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38939-lupin-somerset-morphine-sulfate-tablets-recall-impurities-risk. Based on FDA recall #D-1245-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1245-2019%22&limit=1).

Lupin Somerset voluntarily recalled Morphine Sulfate Extended-Release Tablets, 60 mg, due to failed impurities and degradation specifications, the FDA said on April 10, 2019. The recall affects 10,284 bottles distributed nationwide.

How to tell if you have it

  • Brand: Lupin Somerset
  • Product: Morphine Sulfate Extended-Release Tablets, 60 mg, 100-count bottles
  • NDC: 43386-542-01
  • Lot codes: S700222 (Exp. Apr 30 2019), S800233 (Exp. Feb 29 2020)
  • Manufacturer: Novel Laboratories, Inc.
  • Units affected: 10,284 bottles

The hazard

The recall was initiated because the Morphine Sulfate Extended-Release Tablets failed impurities and degradation specifications. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Lupin Somerset has had 8 other recalls on record since May 24, 2018. Other recent recalls of similar products include Gavilyte-N Packets (March 19, 2019), Fluocinolone Acetonide Topical Solution (Jan. 15, 2019), and Nitrofurantoin Oral Suspension (Dec. 21, 2018). Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection (Feb. 4, 2026), Lupin Sertraline Tablets (Nov. 5, 2025), and Lupin Ganirelix Acetate Injection (Nov. 13, 2025).

How to tell if you have this one

Check for the product name 'Morphine Sulfate Extended-Release Tablets, 60 mg, 100-count bottles' with NDC 43386-542-01 and lot numbers S700222 (expiring April 2019) or S800233 (expiring February 2020).

  • Brand
    Lupin Somerset
  • Category
    Drug
FDA recall event · 5 products

All 5 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.
  • NDC
    43386-540-01, 43386-540-05, 43386-541-01, 43386-541-05, 43386-542-01, 43386-542-05, 43386-543-01, 43386-543-05, 43386-544-01, 43386-544-05
Recall numberProduct, codes & lotsQuantity
D-1243-2019Morphine Sulfate Extended-Release Tablets, 15 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-540-01; Lot#: S700220, Exp. Apr 30 2019; S700604, Exp. July 31 2019; S800326, Exp. Mar 31 202017,328 bottles
D-1244-2019Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-541-01; Lot#: S700221, Exp. Apr 30 2019; S700605, Exp. July 31 2019; S800232, Exp. Feb 29 2020.15,320 bottles
D-1245-2019Morphine Sulfate Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-542-01; Lot#: S700222 Exp. Apr 30 2019 ; S800233 Exp, Feb 29 202010,284 bottles
D-1246-2019Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-543-01; Lot#: S700223 Exp. Apr 30 2019; S800467, Exp. Mar 31 2020.3,444 bottles
D-1247-2019Morphine Sulfate Extended-Release Tablets, 200 mg Rx Only 100 Tablets Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-544-01; Lot#: S700224 Exp. Apr 30 2019; S800469 Exp. Mar 31 2020324 bottles
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the NDC number 43386-542-01 and lot numbers S700222 or S800233 on the bottle.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.5 years after the firm started it.

1. Firm started the recall: Apr 10, 201912. FDA classified it Class III: Apr 25, 201923. Published in FDA’s Enforcement Report: May 1, 201934. FDA terminated the recall: Oct 14, 2022420192022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1245-2019 (April 10, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1245-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA